Diagnostic Utility of Trio–Exome Sequencing for Children With Neurodevelopmental Disorders
JAMA Network Open · 25.03.2025 · 8 (3) · e251807
DOI: 10.1001/jamanetworkopen.2025.1807 ↗Kurz gefasst
Fachartikel in der Zeitschrift JAMA Network Open, online erschienen am 25.03.2025. Verfasst von Xiaoping Lan und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory, Shanghai Children's Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China. Hauptthemen laut MEDLINE: Neurodevelopmental Disorders, Exome Sequencing. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Importance Copy number variants (CNVs) and single-nucleotide variations (SNVs) or insertions and deletions are key genetic contributors to neurodevelopmental disorders (NDDs). Traditionally, chromosome microarray and exome sequencing (ES) have been used to detect CNVs and single gene variants, respectively.
Objective
To identify genetic variants causing NDDs and evaluate the diagnostic yield and clinical utility of ES by simultaneously analyzing CNVs and SNVs in patients with NDDs and their biologic parents (trios). Design, Setting, and Participants This retrospective cohort study included pediatric patients with suspected NDDs who visited Shanghai Children’s Hospital between January 1, 2018, and December 31, 2023. ES was used to investigate trios (trio-ES) including patients with NDDs who remained undiagnosed after phenotype identification and underwent gene panel testing, multiplex ligation-dependent probe amplification, or karyotyping. Comprehensive clinical and laboratory data were collected. Data were analyzed from July 2022 to December 2023. Exposure NDDs, characterized by global developmental delay or intellectual disability. Main Outcomes and Measures The study measured the overall diagnostic yield of SNVs and CNVs in the NDD cohort as well as within NDD syndromic subtypes.
Results
Of the 1106 patients with NDDs, 731 (66.1%) were male. The mean (SD) age of patients at diagnosis was 3.80 (2.82) years. The overall diagnostic yield of trio-ES was 46.1% (510 diagnoses among 1106 patients), with 149 CNVs (13.5%), 355 SNVs (32.1%), and 4 cases of uniparental disomy (0.4%). Codiagnosis of SNVs and CNVs occurred in 2 cases (0.2%). Among the trios, 812 candidate germline variants were identified, including 634 SNVs (78.1%), 174 CNVs (21.4%), and 4 cases of uniparental disomy (0.5%). Of these, 423 SNVs (66.7%) and 157 CNVs (90.2%) were diagnostic variants, while 211 SNVs (33.3%) and 17 CNVs (9.8%) were variants of uncertain significance. Sixteen CNVs smaller than 20 kilobase were detected using ES. Conclusions and Relevance In this cohort study, trio-ES, by simultaneously detecting SNVs and CNVs, achieved a diagnostic yield of 46.1%. Trio-ES may be particularly applicable for identifying small CNVs and recessive genetic diseases involving both SNVs and CNVs. These findings suggest that in clinical practice, simultaneously analyzing SNVs and CNVs using trio-ES data has a favorable genetic diagnostic yield for children with NDDs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Clinical Laboratory, Shanghai Children's Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
- Institute of Pediatric Infection, Immunity, and Critical Care Medicine, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- College of Health Science and Technology, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- Shanghai Engineering Research Center for Big Data in Pediatric Precision Medicine, Shanghai Children's Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
- Center for Biomedical Informatics, Shanghai Children's Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
- Department of Ophthalmology, Shanghai Children's Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Zitieren
APA
Lan, X., Tang, X., Weng, W., Xu, W., Song, X., Yang, Y., Sun, H., Ye, H., Zhang, H., Yu, G., & Wu, S. (2025). Diagnostic Utility of Trio–Exome Sequencing for Children With Neurodevelopmental Disorders. JAMA Network Open, 8(3), e251807. https://doi.org/10.1001/jamanetworkopen.2025.1807
Vancouver
Lan X, Tang X, Weng W, Xu W, Song X, Yang Y, et al. Diagnostic Utility of Trio–Exome Sequencing for Children With Neurodevelopmental Disorders. JAMA Network Open. 2025;8(3):e251807. doi:10.1001/jamanetworkopen.2025.1807
BibTeX
@article{Lan2025,
author = {Lan, Xiaoping and Tang, Xiaojun and Weng, Wenhao and Xu, Wuhen and Song, Xiaozhen and Yang, Yongchen and Sun, Hong and Ye, Haiyun and Zhang, Hong and Yu, Guangjun and Wu, Shengnan},
title = {Diagnostic Utility of Trio–Exome Sequencing for Children With Neurodevelopmental Disorders},
journal = {JAMA Network Open},
year = {2025},
volume = {8},
number = {3},
pages = {e251807},
doi = {10.1001/jamanetworkopen.2025.1807}
}
EUVIMED